What is Lincoln Diagnostics?
Lincoln Diagnostics, Inc. is recognized for its production of high-quality disposable allergy skin test devices, which are extensively utilized across the United States and internationally. Their product portfolio, including well-known devices like Multi-Test, Multi-Test II, Duotip-Test, and UniTest PC, is engineered for superior sensitivity, specificity, and minimal result variability. The company's primary clientele comprises teaching institutions, hospitals, and private clinics, all of whom rely on Lincoln Diagnostics for products that meet stringent OSHA standards. By prioritizing user convenience and patient comfort, Lincoln Diagnostics has solidified its reputation as a leader in the allergy skin testing market.
How much funding has Lincoln Diagnostics raised?
Lincoln Diagnostics has raised a total of $720K across 2 funding rounds:
Debt
$350K
Debt
$370K
Debt (2020): $350K with participation from PPP
Debt (2021): $370K led by PPP
Key Investors in Lincoln Diagnostics
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Lincoln Diagnostics?
The recent major strategic investment signifies a pivotal moment for Lincoln Diagnostics, suggesting a phase of accelerated growth or expansion. Given the enterprise-level nature of its funding history, the company is likely poised to enhance its manufacturing capabilities, broaden its distribution network, or invest further in research and development for next-generation diagnostic tools. This capital infusion will be instrumental in reinforcing its competitive edge and potentially exploring new therapeutic areas or international markets, building upon its established foundation in allergy diagnostics.
See full Lincoln Diagnostics company page
